Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Maxcyte (MXCT) Depreciation & Amortization - Total (2024 - 2025)

Maxcyte (MXCT) has disclosed Depreciation & Amortization - Total for 2 consecutive years, with $1.1 million as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization - Total changed 0.19% to $1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.2 million through Dec 2025, changed 0.09% year-over-year, with the annual reading at $4.3 million for FY2025, 0.65% down from the prior year.
  • Depreciation & Amortization - Total for Q4 2025 was $1.1 million at Maxcyte, roughly flat from $1.1 million in the prior quarter.
  • The five-year high for Depreciation & Amortization - Total was $1.1 million in Q2 2025, with the low at $1.1 million in Q4 2025.